# China Swollen Knee Treatment Market

> China Swollen Knee Treatment Market Research Report: By Type (Medications, Surgery) andBy End User (Hospitals, Clinics) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.57%
- **2024:** $ 81 Million
- **2025:** $ 85.51 Million
- **2035:** $ 147 Million
- **Key Players:** Johnson & Johnson (US), Pfizer Inc. (US), Bayer AG (DE), Novartis AG (CH), AbbVie Inc. (US), GlaxoSmithKline plc (GB), Merck & Co., Inc. (US), Sanofi S.A. (FR)

**Report ID:** MRFR/HC/55036-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/china-swollen-knee-treatment-market-56802

---

## Market Summary

## **China Swollen Knee Treatment Market Overview****:**

As per MRFR analysis, the China Swollen Knee Treatment Market Size was estimated at 76.8 (USD Million) in 2024.The China Swollen Knee Treatment Market Industry is expected to grow from 81(USD Million) in 2025 to 175 (USD Million) by 2035. The China Swollen Knee Treatment Market CAGR (growth rate) is expected to be around 7.254% during the forecast period (2025 - 2035).

### **Key China Swollen Knee Treatment Market Trends Highlighted**

The China Swollen Knee Treatment Market is experiencing notable trends driven by the increasing prevalence of knee-related disorders and the growing aging population in the country. As society ages, many people are experiencing joint problems, including swollen knees, leading to a higher demand for effective treatment options. Traditional Chinese medicine is becoming more widely accepted as an alternative or complementary treatment, reflecting a cultural shift towards holistic health approaches.

Additionally, there is a rising awareness among the population regarding the benefits of early intervention, influencing the demand for various therapeutic options such as physical therapy, medications, and minimally invasive surgical procedures.Opportunities to be explored in this market include the development of innovative treatment solutions and the integration of advanced technologies in treatment modalities. 

The Chinese government encourages research and development in the healthcare sector, which provides a favorable environment for companies to introduce new products that target swollen knee conditions. Moreover, the rising trend of health consciousness among consumers opens doors for alternative therapies and natural remedies that promote joint health. Recent times have seen a trend towards personalized treatment plans tailored to individual patient needs, leveraging advancements in medical technology and data analysis.

This shift is supported by healthcare policies aiming to improve patient outcomes and the overall efficiency of treatment. Furthermore, telemedicine and digital health services are becoming popular, providing patients with access to consultations and follow-ups regarding swollen knee treatments without the need for physical visits to medical facilities. This trend aligns with the broader digital transformation in the healthcare sector in China. Overall, the China Swollen Knee Treatment Market is shaping up to be dynamic, influenced by demographic changes, technological advancements, and evolving consumer preferences.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **China Swollen Knee Treatment Market Drivers**

### **Increasing Prevalence of Osteoarthritis and Other Joint Disorders**

The growing prevalence of osteoarthritis and other joint disorders significantly drives the China Swollen Knee Treatment Market Industry. According to the Chinese National Health Commission, around 60 million individuals in China suffer from osteoarthritis, which is expected to increase due to the aging population. With over 250 million people aged 60 and above by 2025, the demand for effective swollen knee treatments will escalate.

Organizations like the China Association of Gerontology and Geriatrics appreciate this trend and are working to develop better healthcare services to cater to the increasing number of affected individuals.This push will subsequently enhance treatment options and increase market growth in the upcoming years.

### **Growing Awareness of Healthcare and Medical Treatments**

There has been a notable increase in awareness regarding health and medical treatments in China, which is pivotal for the China Swollen Knee Treatment Market Industry. The Chinese government has been actively promoting healthcare education and preventive measures. As a result, patients are more likely to seek medical attention for swollen knees caused by various conditions, leading to increased treatment availability.

Recent data from the Ministry of Health highlight that around 40% of patients are now aware of available treatment options, up from only 25% five years earlier.This growing awareness significantly influences the purchasing behavior of individuals toward knee treatment products.

### **Technological Advancements in Medical Treatments**

Technological advancements, particularly in medical treatments and orthopedic procedures, serve as a significant driver of the China Swollen Knee Treatment Market Industry. Innovations such as minimally invasive surgical techniques and new drug formulations have emerged as game changers. Reports from the National Medical Products Administration indicate that over 30 new orthopedic devices and treatments have received approval for marketing in just the last two years.Organizations like China Biologic Products Holdings have been leading these innovations, which have enabled better patient results and will, as a result, advance growth within the market through greater treatment effectiveness.

### **Government Initiatives and Policy Support**

Government initiatives and policy support are essential drivers for the China Swollen Knee Treatment Market Industry. The Chinese government has prioritized healthcare improvement in its Five-Year Plans, focusing on expanding access to treatment and promoting research in orthopedic care. This includes significant funding for clinical research and collaboration with medical institutions, aiming to develop advanced treatment solutions. For example, the 13th Five-Year Plan for Health emphasizes the importance of chronic disease management, which encompasses joint and musculoskeletal diseases.Such initiatives ensure a supportive environment for market growth and encourage the introduction of new products and services.

## **China Swollen Knee Treatment Market Segment Insights****:**

### **Swollen Knee Treatment Market Type Insights**

The China Swollen Knee Treatment Market encompasses a diverse array of approaches categorized under the Type segment, focusing primarily on Medications and Surgery. This market is witnessing considerable traction due to the rising incidence of knee-related ailments which calls for effective treatment options. In recent years, Medications emerged as a vital aspect of treatment, providing patients with symptomatic relief and management of underlying conditions such as arthritis, gout, and injuries. 

The growing awareness about these therapies in China is bolstered by ongoing initiatives promoting health literacy and access to necessary treatments.On the other hand, Surgery represents a significant pillar of the market, often considered when conservative measures, such as medications, fail to provide adequate relief. Surgical interventions, including arthroscopy and knee replacements, leverage advanced technology and techniques, contributing to better patient outcomes. 

China’s aging population further intensifies the demand for surgical interventions as age-related degenerative diseases become more prevalent. With an increased focus on healthcare reforms and investment in medical infrastructure over the years, both these treatment types are witnessing innovations that aim to enhance efficacy and patient satisfaction.The government has also actively encouraged Research and Development in this space to improve existing therapeutic modalities. 

As segments of the market continue to evolve, they present lucrative opportunities for stakeholders, all while addressing the specific needs and preferences of the Chinese population. Importantly, patient-centric approaches are becoming more prominent, thereby driving the adoption of innovative solutions in Medications and advanced surgical techniques. The integration of medical technology in these treatments not only streamlines the patient journey but also enhances overall treatment efficacy, showcasing the dynamic nature of the China Swollen Knee Treatment Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Swollen Knee Treatment Market End User Insights**

The China Swollen Knee Treatment Market has shown considerable segmentation along the lines of End User, which includes Hospitals and Clinics. As an essential facet of the healthcare system, Hospitals often provide comprehensive resources for the diagnosis and treatment of swollen knee conditions. 

These facilities usually have advanced medical equipment and specialists, positioning themselves as a critical point for patient care in urban areas. Clinics, on the other hand, play a significant role in the early diagnosis and management of such conditions, often serving rural and suburban populations with immediate care access.The accessibility and convenience offered by Clinics contribute substantially to the overall treatment landscape, making them vital in understanding patient inflow and referral pathways. 

The growing prevalence of knee ailments within the elderly demographic in China, coupled with increasing healthcare awareness, has propelled the importance of both Hospitals and Clinics in providing timely and effective treatments. Trends such as integrative care models and telemedicine are also influencing patient choices and experiences in these settings. The China Swollen Knee Treatment Market data illustrates that addressing the distinct needs of these segments can lead to improved health outcomes and patient satisfaction.

## **China Swollen Knee Treatment Market Key Players and Competitive Insights****:**

The China Swollen Knee Treatment Market is characterized by a dynamic landscape that blends innovation, strategic partnerships, and competitive positioning as various companies strive to capture market share and meet consumer needs. With an increasing prevalence of knee-related disorders driven by an aging population and a rise in sports injuries, multiple players are focusing on advancing treatment modalities. 

This sector is increasingly defined by the adoption of advanced technologies and a more personalized approach to treatment, which have spurred competition among pharmaceutical firms and medical device manufacturers. The competitive environment is shaped by a combination of established entities and emerging start-ups that seek to introduce novel therapies and management solutions for swollen knees.Amgen has established a robust presence within the China Swollen Knee Treatment Market, leveraging its extensive research and development to deliver innovative therapeutic options specifically for joint-related conditions. 

The company stands out with its proven strength in biologics and targeted therapies, which are crucial given the market's demand for effective interventions. Amgen’s commitment to advancing care is evident in its focus on precision medicine and its robust pipeline of products that cater to the specific needs of patients suffering from swollen knees.

Furthermore, Amgen has forged strategic collaborations with local healthcare organizations to deepen its market penetration and enhance patient access to its therapies, thereby strengthening its competitive edge in China.Teva Pharmaceuticals plays a significant role in the China Swollen Knee Treatment Market, known for its broad portfolio of generic and specialty medications. 

The company actively engages in the development of treatments that specifically address inflammation and pain management associated with swollen knees, enhancing its market relevance. Teva's strengths lie in its established supply chain and distribution networks, enabling it to efficiently deliver products throughout the region. The company remains proactive in pursuing strategic mergers and acquisitions, which enhance its capabilities and product offerings tailored to the Chinese market. Teva's commitment to affordability and accessibility of medications, combined with its emphasis on quality, positions it favorably against competitors in the swollen knee treatment domain.

### **Key Companies in the China Swollen Knee Treatment Market Include:**

- Amgen
- Teva Pharmaceuticals
- Merck & Co
- Bayer
- GSK
- AbbVie
- Celgene
- Regeneron Pharmaceuticals
- Roche
- Sanofi
- Boehringer Ingelheim
- Novartis
- Johnson & Johnson
- Pfizer

## **China Swollen Knee Treatment Market Industry Developments**

Recent developments in the China Swollen Knee Treatment Market have been influenced by key players such as Amgen, Teva Pharmaceuticals, Merck and Co, Bayer, and GSK, focusing on advancements in pharmaceuticals aimed specifically at osteoarthritis and inflammation. The market has seen a substantial increase in demand for biologics and targeted therapies, attributed to the growing aging population in China and rising prevalence of knee-related disorders. Significant market valuation growth has occurred, with projections indicating further expansion, driven by increased healthcare investments and a shift toward innovative treatments.

In 2023, AbbVie and Regeneron Pharmaceuticals announced their collaboration on developing next-generation therapeutics for joint diseases, reflecting a notable trend toward strategic partnerships. 

_The Chinese market is also witnessing an influx of international firms, including Roche and Sanofi, seeking to diversify their portfolios. Notably, in March 2022, Novartis expanded its research presence in China to focus on chronic pain management, including knee treatment. Furthermore, comprehensive policy support from the Chinese government has accelerated research and development initiatives in the field, ensuring a robust framework for treatment advancements over the coming years._

## **China Swollen Knee Treatment Market Segmentation Insights**

### **Swollen Knee Treatment Market Type****Outlook**

- Medications
- Surgery

### **Swollen Knee Treatment Market End User****Outlook**

- Hospitals
- Clinics

## Market Drivers

### Rising Healthcare Expenditure

China's increasing healthcare expenditure is a significant driver for the swollen knee-treatment market. The government has been investing heavily in healthcare infrastructure and services, aiming to provide better access to medical care for its citizens. In recent years, healthcare spending has risen to approximately 6% of GDP, reflecting a commitment to improving health outcomes. This financial support facilitates the availability of advanced treatment options and encourages research and development in the swollen knee-treatment market. As more individuals gain access to healthcare services, the demand for effective knee treatments is expected to rise. Additionally, the expansion of health insurance coverage further alleviates the financial burden on patients, making treatments more accessible and driving market growth.

### Advancements in Medical Technology

Technological innovations in medical devices and treatment methodologies are transforming the swollen knee-treatment market. The introduction of minimally invasive surgical techniques and advanced imaging technologies enhances diagnostic accuracy and treatment efficacy. For instance, arthroscopy has become a preferred method for treating knee issues, allowing for quicker recovery times and reduced hospital stays. The swollen knee-treatment market is witnessing a shift towards integrating artificial intelligence and machine learning in treatment planning, which could potentially improve patient outcomes. Moreover, the development of smart wearable devices for monitoring knee health is gaining traction, providing patients and healthcare professionals with real-time data. This technological evolution not only improves treatment options but also increases patient engagement, thereby driving market growth.

### Expansion of Rehabilitation Services

The expansion of rehabilitation services in China is a crucial driver for the swollen knee-treatment market. As the healthcare system evolves, there is a growing recognition of the importance of rehabilitation in the recovery process for knee disorders. Facilities offering specialized rehabilitation programs are becoming more prevalent, providing patients with tailored treatment plans that include physical therapy and post-operative care. This trend is likely to enhance patient outcomes and satisfaction, thereby increasing the demand for services within the swollen knee-treatment market. Additionally, the integration of rehabilitation services with traditional medical treatments may lead to a more holistic approach to knee health, further driving market growth as patients seek comprehensive care.

### Increasing Prevalence of Knee Disorders

The rising incidence of knee disorders in China is a primary driver for the swollen knee-treatment market. Factors such as an aging population, sedentary lifestyles, and increased obesity rates contribute to this trend. According to recent health statistics, approximately 30% of adults over 60 years old experience knee-related issues, which significantly impacts their quality of life. This demographic shift necessitates effective treatment options, thereby expanding the market. Furthermore, the swollen knee-treatment market is likely to see a surge in demand for both surgical and non-surgical interventions as healthcare providers aim to address these growing concerns. The increasing awareness of knee health among the population also plays a crucial role in driving market growth, as individuals seek timely treatment to avoid complications.

### Growing Awareness of Preventive Healthcare

There is a notable increase in awareness regarding preventive healthcare in China, which significantly impacts the swollen knee-treatment market. As individuals become more informed about the importance of maintaining joint health, they are more likely to seek early intervention for knee issues. Educational campaigns and community health programs are promoting the benefits of preventive measures, such as regular exercise and weight management, to reduce the risk of knee disorders. This shift towards proactive health management is likely to drive demand for treatments in the swollen knee-treatment market. Furthermore, healthcare providers are increasingly focusing on preventive strategies, which may lead to a rise in consultations and treatments aimed at preventing the progression of knee-related conditions.

## Future Outlook

The [Swollen Knee Treatment Market](https://www.marketresearchfuture.com/reports/swollen-knee-treatment-market-6406) in China is projected to grow at a 5.57% CAGR from 2025 to 2035, driven by increasing prevalence of knee disorders and advancements in treatment technologies.

**New opportunities:**

- Development of telehealth platforms for remote consultations and follow-ups.
- Investment in regenerative medicine technologies for knee treatment.
- Expansion of targeted marketing strategies for orthopedic clinics and hospitals.

By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment methodologies and patient needs.

## Segment Insights

### By Type: Medications (Largest) vs. Surgery (Fastest-Growing)

In the China swollen knee-treatment market, the segment is primarily dominated by Medications, which capture a significant market share due to their widespread availability and acceptance among patients. This category includes various analgesics and anti-inflammatory drugs that are commonly prescribed for managing symptoms associated with swollen knees. On the other hand, Surgery is emerging rapidly, driven by increasing patient demand for long-term solutions and the advancement of surgical techniques and technologies.

Growth trends within the segment indicate a consistent rise in the adoption of Surgery as a viable option for treating swollen knees, fueled by the aging population and a rise in orthopedic surgeries. Additionally, Medications continue to grow steadily, but their growth is moderate compared to Surgery's dynamic increase. The preference for minimally invasive procedures and improved recovery times are influencing patients and healthcare providers alike, shifting focus towards surgical interventions for more effective and enduring relief.

Medications (Dominant) vs. Surgery (Emerging)

Medications represent the dominant force in the China swollen knee-treatment market, offering a broad range of treatment options that address pain and inflammation. This segment encompasses over-the-counter and prescription drugs, making them accessible to a large patient base. The efficacy and convenience of medications solidify their position as the first line of treatment for knee swelling issues. In contrast, Surgery is identified as an emerging solution, appealing to patients seeking definitive and long-term relief from knee problems. Surgical options are becoming increasingly sophisticated and less invasive, attracting a growing number of patients. As patients become more informed, the potential of surgical interventions continues to gain traction in the market, offering a promising alternative to traditional medical therapies.

### By End-User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

The distribution of market share among various end-users in the swollen knee-treatment market reveals that hospitals hold the largest share, boasting significant infrastructure and specialized staff for comprehensive treatment. In contrast, clinics have carved out a notable niche, driven by increasing patient flow seeking less invasive procedures and tailored treatment options.

Growth trends in this segment indicate an upward trajectory for clinics, which are rapidly adapting to patient demands for convenience and accessibility. Factors fueling this growth include advancements in minimally invasive technologies and a growing population segment seeking outpatient care solutions. Additionally, the overall healthcare ecosystem in China is shifting towards decentralized models, further promoting the clinic's rise.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals, as the dominant players in the swollen knee-treatment market, are characterized by their comprehensive service offerings and extensive resources for pre-operative and post-operative care. Equipped with advanced imaging technologies and surgical capabilities, hospitals provide a wide array of treatment options including surgical interventions and rehabilitative therapies. Conversely, clinics are emerging as an attractive option due to their focus on outpatient care, enabling faster treatment cycles and reduced patient wait times. Many clinics are leveraging telemedicine and innovative care models to attract patients, positioning themselves as vital components within the healthcare framework. This trend toward outpatient services reflects changing consumer preferences for convenience, driving growth and enhancing competition between these end-user categories.

## Competitive Benchmarking

The swollen knee-treatment market in China is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Johnson & Johnson (US), Pfizer Inc. (US), and AbbVie Inc. (US) are actively pursuing strategies that emphasize product development and market penetration. Johnson & Johnson (US) has focused on enhancing its portfolio of orthopedic solutions, while Pfizer Inc. (US) is leveraging its extensive research capabilities to develop novel therapies. AbbVie Inc. (US) appears to be concentrating on strategic collaborations to bolster its market presence, indicating a trend towards cooperative strategies among leading firms.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive dynamic suggests that while there is room for smaller entities, the strategic maneuvers of larger firms will likely dictate market trends and consumer preferences.

In October  Pfizer Inc. (US) announced a partnership with a local Chinese biotech firm to co-develop a new treatment for knee osteoarthritis. This collaboration is significant as it not only enhances Pfizer's research capabilities but also allows for a more tailored approach to the Chinese market, potentially increasing patient access to innovative therapies. Such partnerships may serve as a model for future collaborations in the region.

In September  AbbVie Inc. (US) launched a new digital health platform aimed at improving patient engagement and adherence to treatment protocols for knee-related conditions. This initiative underscores the growing importance of digital transformation in healthcare, as it seeks to empower patients and streamline treatment processes. The strategic importance of this move lies in its potential to enhance patient outcomes and foster brand loyalty in a competitive market.

In August  Johnson & Johnson (US) expanded its manufacturing capabilities in China, investing approximately $50 million in a new facility dedicated to orthopedic products. This expansion reflects a commitment to meeting local demand and optimizing supply chain logistics. The strategic importance of this investment is multifaceted, as it not only positions Johnson & Johnson to respond swiftly to market needs but also reinforces its competitive edge in a rapidly evolving landscape.

As of November  the competitive trends in the swollen knee-treatment market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative treatment solutions, and reliable supply chains. This shift may redefine how companies position themselves in the market, emphasizing the need for agility and responsiveness to changing consumer demands.

## Recent News & Developments

Recent developments in the China Swollen Knee Treatment Market have been influenced by key players such as Amgen, Teva Pharmaceuticals, Merck and Co, Bayer, and GSK, focusing on advancements in pharmaceuticals aimed specifically at osteoarthritis and inflammation. The market has seen a substantial increase in demand for biologics and targeted therapies, attributed to the growing aging population in China and rising prevalence of knee-related disorders. Significant market valuation growth has occurred, with projections indicating further expansion, driven by increased healthcare investments and a shift toward innovative treatments.

In 2023, AbbVie and Regeneron Pharmaceuticals announced their collaboration on developing next-generation therapeutics for joint diseases, reflecting a notable trend toward strategic partnerships. 

_The Chinese market is also witnessing an influx of international firms, including Roche and Sanofi, seeking to diversify their portfolios. Notably, in March 2022, Novartis expanded its research presence in China to focus on chronic pain management, including knee treatment. Furthermore, comprehensive policy support from the Chinese government has accelerated research and development initiatives in the field, ensuring a robust framework for treatment advancements over the coming years._

## Report Scope

| MARKET SIZE 2024 | 81.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 85.51(USD Million) |
| MARKET SIZE 2035 | 147.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.57% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Johnson & Johnson (US), Pfizer Inc. (US), Bayer AG (DE), Novartis AG (CH), AbbVie Inc. (US), GlaxoSmithKline plc (GB), Merck & Co., Inc. (US), Sanofi S.A. (FR) |
| Segments Covered | Type, End-User |
| Key Market Opportunities | Emergence of innovative therapies and personalized treatments in the swollen knee-treatment market. |
| Key Market Dynamics | Rising demand for innovative therapies drives competition in the swollen knee-treatment market amid evolving regulatory frameworks. |
| Countries Covered | China |

## Frequently Asked Questions

**Q: What was the market valuation for swollen knee treatment in 2024?**
A: The market valuation for swollen knee treatment was $81.0 Million in 2024.

**Q: What is the projected market valuation for swollen knee treatment by 2035?**
A: The projected market valuation for swollen knee treatment is $147.0 Million by 2035.

**Q: What is the expected CAGR for the swollen knee treatment market during 2025 - 2035?**
A: The expected CAGR for the swollen knee treatment market during 2025 - 2035 is 5.57%.

**Q: Which companies are the key players in the swollen knee treatment market?**
A: Key players in the swollen knee treatment market include Johnson & Johnson, Pfizer Inc., Bayer AG, Novartis AG, AbbVie Inc., GlaxoSmithKline plc, Merck & Co., Inc., and Sanofi S.A.

**Q: What are the main segments of the swollen knee treatment market?**
A: The main segments of the swollen knee treatment market include medications, patient-controlled analgesia (PCA) pumps, nerve blocks, liposomal bupivacaine, and surgery.

**Q: How much revenue did medications generate in the swollen knee treatment market in 2024?**
A: Medications generated between $30.0 Million and $54.0 Million in the swollen knee treatment market in 2024.

**Q: What is the revenue range for surgery in the swollen knee treatment market?**
A: The revenue range for surgery in the swollen knee treatment market is between $21.0 Million and $38.0 Million.

**Q: Which end-users are involved in the swollen knee treatment market?**
A: End-users in the swollen knee treatment market include hospitals, clinics, ambulatory surgery centers, and others.

**Q: What revenue did hospitals generate in the swollen knee treatment market in 2024?**
A: Hospitals generated between $30.0 Million and $54.0 Million in the swollen knee treatment market in 2024.

**Q: What is the projected growth trend for the swollen knee treatment market?**
A: The swollen knee treatment market is expected to grow steadily, reaching $147.0 Million by 2035, indicating a positive growth trend.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-swollen-knee-treatment-market-56802*